CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Immune to Cancer: The CRI Blog

  • AACR19 Day 4 Update: The Microbiome, Immunotherapy Biomarkers, and New Immune Targets

    Day 4 of AACR19 explored the microbiome and its impact on cancer treatment, revealed insights into immunotherapy…

    April 2, 2019| Arthur N. Brodsky, PhD
  • AACR19 Day 3 Update: CAR T Cells, Vaccines, and Hope Against Pancreatic Cancer

    In addition to advances involving CAR T cell therapy and vaccines, a CRI-funded trial revealed the promise…

    April 1, 2019| Arthur N. Brodsky, PhD
  • AACR19 Preview: CRI Scientists Showcase the Future of Immunotherapy

    The 2019 AACR annual meeting kicks off March 29 in Atlanta and will feature the work of…

    March 23, 2019| Arthur N. Brodsky, PhD
  • AACR18 Recap: Immunotherapy in the Spotlight

    Immunotherapy took center stage and dominated the headlines at AACR18.

    April 23, 2018| Arthur N. Brodsky, PhD
  • AACR18 Update: Lloyd J. Old Award, Overcoming Immunotherapy Resistance, and the Importance of Dendritic Cells

    Day 4 at AACR18 was a special day for CRI’s Dr. Antoni Ribas, and highlighted his and…

    April 18, 2018| Arthur N. Brodsky, PhD
  • AACR18 Day 3 Update: Lung Cancer in the Spotlight, Immune Memory, and New Immunotherapy Biomarkers

    Day 3 of AACR18 highlighted potentially “practice-changing” immunotherapy breakthroughs in lung cancer, and insights into the factors…

    April 17, 2018| Arthur N. Brodsky, PhD
  • AACR18 Day 2 Update: What’s Next for Cancer Immunotherapy?

    CRI scientists kicked off the opening plenary session at AACR18 and discussed several promising avenues of immunotherapy…

    April 16, 2018| CRI Staff
  • AACR18: Driving Innovative Cancer Science to Patient Care

    This year’s annual AACR meeting boasts an impressive lineup of presentations highlighting both clinical and preclinical immunotherapy…

    April 12, 2018| Arthur N. Brodsky, PhD
  • AACR17 Update: Checkpoint Immunotherapy Clinical Trials in Melanoma and Lung Cancer

    In-depth analysis of long-term clinical trial data provides important insights for doctors treating…

    April 6, 2017| Arthur N. Brodsky, PhD
Previous Page
1 2 3 4 5
Next Page

Cancer Research Institute
29 Broadway, Floor 4

New York, NY  10006-3111

Facebook Icon
X icon
YouTube icon
LinkedIn icon
Instagram icon
Threads icon
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Type
    • Cancer Type
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Donate
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact

Uniting for a World Immune to Cancer

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
  • Site Map

*Immunotherapy results may vary from patient to patient.

©2025, Cancer Research Institute